Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma: Resistance to Melanoma Targeted Therapy

    loading  Checking for direct PDF access through Ovid

Abstract

Selective kinase inhibitors have vastly improved the survival of patients with advanced melanoma, but drug resistance remains a major clinical challenge. Understanding the mechanisms of resistance may provide insights into new combination treatments and novel therapeutic targets that can prevent resistance.

Related Topics

    loading  Loading Related Articles